Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial (Q45842857)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial |
scientific article |
Statements
1 reference
Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial (English)
1 reference
Gerd R Burmester
1 reference
Ricardo Blanco
1 reference
Christina Charles-Schoeman
1 reference
Jürgen Wollenhaupt
1 reference
Cristiano Zerbini
1 reference
Birgitta Benda
1 reference
David Gruben
1 reference
Gene Wallenstein
1 reference
Sriram Krishnaswami
1 reference
Samuel H Zwillich
1 reference
Tamas Koncz
1 reference
Koshika Soma
1 reference
John Bradley
1 reference
Charles Mebus
1 reference
ORAL Step investigators
1 reference
5 January 2013
1 reference
1 reference
381
1 reference
9865
1 reference
451-460
1 reference
Identifiers
1 reference